نتائج البحث - David C. Smith
- يعرض 1 - 20 نتائج من 63
- اذهب إلى الاصفحة التالية
-
1
Small-molecule SMAC mimetics as new cancer therapeutics حسب Longchuan Bai, David C. Smith, Shaomeng Wang
منشور في 2014Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
Combined-Modality Therapy With Gemcitabine and Radiotherapy As a Bladder Preservation Strategy: Results of a Phase I Trial حسب Elizabeth C. Kent, Howard M. Sandler, James E. Montie, Cheryl Lee, Joseph M. Herman, Peg Esper, Judith Fardig, David C. Smith
منشور في 2004Artigo -
9
-
10
Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours حسب Patrick Schöffski, Michael S. Gordon, David C. Smith, Razelle Kurzrock, Adil Daud, Nicholas J. Vogelzang, Yihua Lee, Christian Scheffold, Geoffrey I. Shapiro
منشور في 2017Artigo -
11
Detection of CTC Clusters and a Dedifferentiated RNA‐Expression Survival Signature in Prostate Cancer حسب Molly Kozminsky, Shamileh Fouladdel, Jae‐Seung Chung, Yugang Wang, David C. Smith, Ajjai Alva, Ebrahim Azizi, Todd M. Morgan, Sunitha Nagrath
منشور في 2018Artigo -
12
-
13
-
14
Cerebral oxygenation during paediatric cardiac surgery: identification of vulnerable periods using near infrared spectroscopy حسب Piers E.F. Daubeney, David C Smith, S N Pilkington, Robert K. Lamb, James L. Monro, VT Tsang, S.A. Livesey, Steven A. Webber
منشور في 1998Artigo -
15
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies حسب Vivek Subbiah, Nicholas Iannotti, Martin Gutierrez, David C. Smith, Luis Féliz, Christine Lihou, Chuan Tian, Ian M. Silverman, Tao Ji, Mansoor N. Saleh
منشور في 2022Artigo -
16
A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors حسب David C. Smith, Rashmi Chugh, Amita Patnaik, Kyriakos P. Papadopoulos, Min Wang, Ann M. Kapoun, Lu Xu, Jakob Dupont, Robert Stagg, Anthony W. Tolcher
منشور في 2018Artigo -
17
Randomized clinical trial of a family intervention for prostate cancer patients and their spouses حسب Laurel Northouse, Darlene Mood, Ann Schafenacker, James E. Montie, Howard M. Sandler, Jeffrey D. Forman, Maha Hussain, Kenneth J. Pienta, David C. Smith, Trace Kershaw
منشور في 2007Artigo -
18
Phase 1/2 dose‐escalation study of a GM‐CSF‐secreting, allogeneic, cellular immunotherapy for metastatic hormone‐refractory prostate cancer حسب Celestia S. Higano, John M. Corman, David C. Smith, Arthur S. Centeno, Christopher P. Steidle, Marc Gittleman, Jonathan W. Simons, Natalie Sacks, Junko Aimi, Eric J. Small
منشور في 2008Artigo -
19
Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) حسب Deborah Bradley, Dana E. Rathkopf, Rodney L. Dunn, Walter M. Stadler, Glenn Liu, David C. Smith, Роберто Пили, James A. Zwiebel, Howard I. Scher, Maha Hussain
منشور في 2009Artigo -
20
A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors حسب David C. Smith, Peter D. Eisenberg, Georgy M. Manikhas, Rashmi Chugh, Matthew A. Gubens, Robert Stagg, Ann M. Kapoun, Lu Xu, Jakob Dupont, Branimir I. Šikić
منشور في 2014Artigo
أدوات البحث:
موضوعات ذات صلة
Medicine
Internal medicine
Cancer
Oncology
Adverse effect
Biology
Gastroenterology
Prostate cancer
Urology
Cancer research
Surgery
Clinical endpoint
Chemotherapy
Gene
Genetics
Immunotherapy
Biochemistry
Clinical trial
Nausea
Pharmacology
Pathology
Prostate
Tolerability
Chemistry
Pharmacodynamics
Pharmacokinetics
Discontinuation
Phases of clinical research
Randomized controlled trial
Toxicity